• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膳食晚期糖基化终产物通过PRMT1介导的CRTC3精氨酸甲基化激活细胞凋亡,从而加剧肌肉减少症的发生。

Dietary advanced glycation end-products exacerbate sarcopenia onset by activating apoptosis through PRMT1-mediated CRTC3 arginine methylation.

作者信息

Huang Tian-Jin, Shang Shu, Wan Qin, Li Qiang, Li Yang-Jingsi, Zheng Jin-Na, Chen Fa-Xiu

机构信息

Department of Geriatrics, Jiangxi Provincial People's Hospital, No. 92 Aiguo Rd, Donghu District, Nanchang, Jiangxi, 330006, China.

Department of Geriatrics, The First Affiliated Hospital of Nanchang Medical College, No. 92 Aiguo Rd, Donghu District, Nanchang, Jiangxi, 330006, China.

出版信息

Cell Mol Life Sci. 2025 Apr 7;82(1):142. doi: 10.1007/s00018-025-05657-1.

DOI:10.1007/s00018-025-05657-1
PMID:40192801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977089/
Abstract

BACKGROUND

Sarcopenia, the age-related decline in muscle mass and function, poses a major health risk to the elderly population. Although dietary advanced glycation end-products (AGEs) have been implicated in worsening sarcopenia, the precise molecular mechanisms remain unclear.

METHODS

A sarcopenia animal model was established by feeding a high AGE diet to C57BL/6 mice. Muscle function and mass were assessed using grip strength tests, and rotarod tests. Proteomic analysis was used to identify differentially expressed proteins. Immunoprecipitation, mass spectrometry, and co-immunoprecipitation were employed to investigate protein interactions both in vivo and in vitro. Quantitative reverse transcription PCR and Western blotting were conducted to measure gene and protein expression levels.

RESULTS

Our results revealed that dietary AGEs accelerated the onset of sarcopenia in mice by triggering apoptosis. Proteomic analysis showed a marked upregulation of protein arginine methyltransferase 1 (PRMT1) in the muscle tissues of mice fed a high AGE diet. PRMT1 mediated the arginine methylation of CREB-regulated transcription coactivator 3 (CRTC3) at the R534 site within its transactivation domain, leading to CRTC3 activation. The activated CRTC3, together with Forkhead box O3a (FOXO3a), transactivated the BAX (BCL2 associated X) gene, initiating Bax downstream signaling, promoting apoptosis in muscle cells, and contributing to muscle atrophy. Inhibition of PRMT1 prevented CRTC3 methylation and suppressed Bax-mediated apoptotic signaling in vitro. Moreover, in vivo treatment with PRMT1 and Bax inhibitors significantly attenuated AGE-induced sarcopenia in mice.

CONCLUSION

PRMT1-mediated CRTC3 arginine methylation plays a critical role in AGE-induced sarcopenia and suggests potential therapeutic targets for preventing sarcopenia progression.

摘要

背景

肌肉减少症是与年龄相关的肌肉质量和功能下降,对老年人群构成重大健康风险。尽管膳食晚期糖基化终产物(AGEs)被认为会加重肌肉减少症,但其确切分子机制仍不清楚。

方法

通过给C57BL/6小鼠喂食高AGE饮食建立肌肉减少症动物模型。使用握力测试和转棒试验评估肌肉功能和质量。蛋白质组学分析用于鉴定差异表达的蛋白质。采用免疫沉淀、质谱和免疫共沉淀技术研究体内和体外的蛋白质相互作用。进行定量逆转录PCR和蛋白质免疫印迹法以测量基因和蛋白质表达水平。

结果

我们的结果表明,膳食AGEs通过触发细胞凋亡加速了小鼠肌肉减少症的发生。蛋白质组学分析显示,喂食高AGE饮食的小鼠肌肉组织中蛋白质精氨酸甲基转移酶1(PRMT1)显著上调。PRMT1介导CREB调节的转录共激活因子3(CRTC3)在其反式激活域内R534位点的精氨酸甲基化,导致CRTC3激活。激活的CRTC3与叉头框O3a(FOXO3a)一起反式激活BAX(BCL2相关X)基因,启动Bax下游信号传导,促进肌肉细胞凋亡,并导致肌肉萎缩。抑制PRMT1可防止CRTC3甲基化,并在体外抑制Bax介导的凋亡信号传导。此外,在体内用PRMT1和Bax抑制剂治疗可显著减轻AGE诱导的小鼠肌肉减少症。

结论

PRMT1介导的CRTC3精氨酸甲基化在AGE诱导的肌肉减少症中起关键作用,并提示了预防肌肉减少症进展的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/cd7b801cc068/18_2025_5657_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/f1a79baec32d/18_2025_5657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/271e91c3ff4b/18_2025_5657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/8f50b69cc8dd/18_2025_5657_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/d4b76ee3557a/18_2025_5657_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/930fb7159fe8/18_2025_5657_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/3f75d2d105c0/18_2025_5657_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/81ff6960a11a/18_2025_5657_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/cd7b801cc068/18_2025_5657_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/f1a79baec32d/18_2025_5657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/271e91c3ff4b/18_2025_5657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/8f50b69cc8dd/18_2025_5657_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/d4b76ee3557a/18_2025_5657_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/930fb7159fe8/18_2025_5657_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/3f75d2d105c0/18_2025_5657_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/81ff6960a11a/18_2025_5657_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a50a/11977089/cd7b801cc068/18_2025_5657_Fig8_HTML.jpg

相似文献

1
Dietary advanced glycation end-products exacerbate sarcopenia onset by activating apoptosis through PRMT1-mediated CRTC3 arginine methylation.膳食晚期糖基化终产物通过PRMT1介导的CRTC3精氨酸甲基化激活细胞凋亡,从而加剧肌肉减少症的发生。
Cell Mol Life Sci. 2025 Apr 7;82(1):142. doi: 10.1007/s00018-025-05657-1.
2
Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.骨骼肌特异性 Prmt1 缺失通过失调的 PRMT6-FOXO3 轴引起肌肉萎缩。
Autophagy. 2019 Jun;15(6):1069-1081. doi: 10.1080/15548627.2019.1569931. Epub 2019 Feb 5.
3
PRMT1-mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation.PRMT1介导的精氨酸甲基化促进YAP激活和肝细胞癌增殖。
FEBS Open Bio. 2024 Dec;14(12):2104-2112. doi: 10.1002/2211-5463.13909. Epub 2024 Oct 4.
4
Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.BCL-2 凋亡蛋白拮抗剂(BAD)的精氨酸甲基化拮抗 Akt 的磷酸化及其失活。
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6085-90. doi: 10.1073/pnas.1015328108. Epub 2011 Mar 28.
5
Prmt1-mediated methylation regulates Ncoa4 stability to transactivate Adamts genes and promote bone extracellular matrix degradation in chronic hematogenous osteomyelitis.Prmt1介导的甲基化调节Ncoa4稳定性,以反式激活Adamts基因并促进慢性血源性骨髓炎中骨细胞外基质的降解。
Biol Direct. 2025 May 9;20(1):60. doi: 10.1186/s13062-025-00652-9.
6
Arginine methylation-dependent regulation of ASK1 signaling by PRMT1.精氨酸甲基化依赖的 PRMT1 对 ASK1 信号的调控。
Cell Death Differ. 2012 May;19(5):859-70. doi: 10.1038/cdd.2011.168. Epub 2011 Nov 18.
7
PRMT1 Upregulates SIRT6 by Enhancing Arginine Methylation of E2F7 to Inhibit Vascular Smooth Muscle Cell Senescence in Aortic Dissection.PRMT1通过增强E2F7的精氨酸甲基化上调SIRT6以抑制主动脉夹层中血管平滑肌细胞衰老
FASEB J. 2025 May 15;39(9):e70579. doi: 10.1096/fj.202403269R.
8
Deep Protein Methylation Profiling by Combined Chemical and Immunoaffinity Approaches Reveals Novel PRMT1 Targets.通过联合化学和免疫亲和方法进行深度蛋白质甲基化分析揭示了新的 PRMT1 靶标。
Mol Cell Proteomics. 2019 Nov;18(11):2149-2164. doi: 10.1074/mcp.RA119.001625. Epub 2019 Aug 26.
9
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.PRMT1 介导的 H4R3me2a 募集 SMARCA4 通过增强 EGFR 信号促进结直肠癌进展。
Genome Med. 2021 Apr 14;13(1):58. doi: 10.1186/s13073-021-00871-5.
10
Protein arginine methyltransferase expression, localization, and activity during disuse-induced skeletal muscle plasticity.在废用性诱导的骨骼肌可塑性过程中,精氨酸甲基转移酶的表达、定位和活性。
Am J Physiol Cell Physiol. 2018 Feb 1;314(2):C177-C190. doi: 10.1152/ajpcell.00174.2017. Epub 2017 Nov 1.

本文引用的文献

1
PRMT1-mediated methylation regulates MLL2 stability and gene expression.蛋白精氨酸甲基转移酶1(PRMT1)介导的甲基化作用调节混合谱系白血病蛋白2(MLL2)的稳定性及基因表达。
Nucleic Acids Res. 2025 Feb 8;53(4). doi: 10.1093/nar/gkae1227.
2
Epigenetic control of skeletal muscle atrophy.骨胳肌萎缩的表观遗传控制。
Cell Mol Biol Lett. 2024 Jul 8;29(1):99. doi: 10.1186/s11658-024-00618-1.
3
Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions - A review.AGEs-RAGE 轴的激活和调节:对炎症性病理和治疗干预的影响——综述。
Pharmacol Res. 2024 Aug;206:107282. doi: 10.1016/j.phrs.2024.107282. Epub 2024 Jun 22.
4
An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and inhibition.糖基化概述:分子机制、对蛋白质的影响、发病机制及抑制作用
Biophys Rev. 2024 Apr 12;16(2):189-218. doi: 10.1007/s12551-024-01188-4. eCollection 2024 Apr.
5
Emerging Therapeutic Strategies in Sarcopenia: An Updated Review on Pathogenesis and Treatment Advances.少肌症的新兴治疗策略:关于发病机制和治疗进展的最新综述
Int J Mol Sci. 2024 Apr 12;25(8):4300. doi: 10.3390/ijms25084300.
6
Association Between Advanced Glycation End Products and Sarcopenia: The Mediating Role of Osteoporosis.晚期糖基化终产物与肌肉减少症之间的关联:骨质疏松症的中介作用
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1105-e1116. doi: 10.1210/clinem/dgad640.
7
Calsarcin-2 May Play a Compensatory Role in the Development of Obese Sarcopenia.钙调肌动蛋白-2可能在肥胖性肌肉减少症的发展中起代偿作用。
Biomedicines. 2023 Oct 5;11(10):2708. doi: 10.3390/biomedicines11102708.
8
Advanced glycation end products promote intervertebral disc degeneration by transactivation of matrix metallopeptidase genes.晚期糖基化终产物通过基质金属蛋白酶基因的转激活促进椎间盘退变。
Osteoarthritis Cartilage. 2024 Feb;32(2):187-199. doi: 10.1016/j.joca.2023.09.005. Epub 2023 Sep 15.
9
The Role of Nutrition in the Treatment of Sarcopenia in Old Patients: From Restoration of Mitochondrial Activity to Improvement of Muscle Performance, a Systematic Review.营养在老年患者肌少症治疗中的作用:从线粒体活性恢复到肌肉性能改善的系统评价。
Nutrients. 2023 Aug 24;15(17):3703. doi: 10.3390/nu15173703.
10
Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review.肌肉减少症的发病机制、干预措施及药物研发现状:综述
Biomedicines. 2023 Jun 4;11(6):1635. doi: 10.3390/biomedicines11061635.